Compounds containing a vascular disrupting agent
Abstract:
The present invention relates to compounds, and pharmaceutically acceptable salts thereof, comprising a vascular disrupting agent (VDA) associated and a MMP proteolytic cleavage site. The compounds are useful in the treatment of cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0